Company intelligence / Profile preview

CELLSCRIPT

Madison, Wisconsin, United Statescellscript.com ↗
Ownership
Private
Employees
~34
Development stage
Commercial
01

Overview

CELLSCRIPT develops and supplies high-quality enzymes, kits, and reagents to enable the production of functional synthetic RNAs—including modified mRNAs—for use in cell-based research and clinical applications. Their technologies are widely used by academic labs, biotech companies, and pharmaceutical firms developing next-generation RNA therapeutics. The company’s products support both preclinical studies and clinical-stage manufacturing of synthetic RNAs.

Modalities
mRNA-based drugsRNA therapyModified nucleoside RNA (e.g., pseudouridine-containing mRNA)Enzyme reagents for in vitro transcription and RNA modification
Industry
Chemicals & Materials
02

Partnerships

BioNTech – non-exclusive patent licensing agreement covering nucleoside-modified messenger RNA technology used in advanced immuno-oncology programsOther partnerships with academic institutions via licensing agreements for patented modified nucleosides from University of Pennsylvania

Beyond the preview

Go deeper on CELLSCRIPT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CELLSCRIPT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call